<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    15142155
   </pmid>
   <datecreated>
    <year>
     2004
    </year>
    <month>
     05
    </month>
    <day>
     14
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2004
    </year>
    <month>
     06
    </month>
    <day>
     08
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2006
    </year>
    <month>
     07
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      1464-4096
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       93
      </volume>
      <issue>
       7
      </issue>
      <pubdate>
       <year>
        2004
       </year>
       <month>
        May
       </month>
      </pubdate>
     </journalissue>
     <title>
      BJU international
     </title>
     <isoabbreviation>
      BJU Int.
     </isoabbreviation>
    </journal>
    <articletitle>
     Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study.
    </articletitle>
    <pagination>
     <medlinepgn>
      1018-21
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="OBJECTIVE" nlmcategory="OBJECTIVE">
      To assess the use of a topical anaesthetic mixture to improve premature ejaculation (PE), for which penile hypersensitivity might be a cause.
     </abstracttext>
     <abstracttext label="PATIENTS AND METHODS" nlmcategory="METHODS">
      The study included 42 men divided in two groups; group A used a lidocaine-prilocaine solution and group B used an inert cream. The tubes of cream were distributed randomly and participants asked to note any unpleasant symptoms, difficulties and the results of each attempt at intercourse, assessed by the intravaginal ejaculatory latency time (IELT).
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      There was a significant increase in the mean (sd) IELT, from 1.49 (0.9) to 8.45 (0.9) min (P &lt; 0.001) in group A but not in group B, at 1.67 (0.7) to 1.95 (0.12) min (P &gt; 0.05).
     </abstracttext>
     <abstracttext label="CONCLUSION" nlmcategory="CONCLUSIONS">
      We suggest that anaesthetic cream might be effective for treating PE.
     </abstracttext>
    </abstract>
    <affiliation>
     Urology Surgery Service, Marieta Konder Bornhausen Hospital, Itaja√≠, Brazil. wbusato@melim.com.br
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Busato
      </lastname>
      <forename>
       W
      </forename>
      <initials>
       W
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Galindo
      </lastname>
      <forename>
       C C
      </forename>
      <initials>
       CC
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     England
    </country>
    <medlineta>
     BJU Int
    </medlineta>
    <nlmuniqueid>
     100886721
    </nlmuniqueid>
    <issnlinking>
     1464-4096
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Anesthetics, Combined
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Anesthetics, Local
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      137-58-6
     </registrynumber>
     <nameofsubstance>
      Lidocaine
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      721-50-6
     </registrynumber>
     <nameofsubstance>
      Prilocaine
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Administration, Topical
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Anesthetics, Combined
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Anesthetics, Local
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Double-Blind Method
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Ejaculation
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Lidocaine
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Prilocaine
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Sexual Dysfunction, Physiological
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
   </meshheadinglist>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2004
     </year>
     <month>
      5
     </month>
     <day>
      15
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2004
     </year>
     <month>
      6
     </month>
     <day>
      21
     </day>
     <hour>
      10
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2004
     </year>
     <month>
      5
     </month>
     <day>
      15
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     15142155
    </articleid>
    <articleid idtype="doi">
     10.1111/j.1464-410X.2003.04773.x
    </articleid>
    <articleid idtype="pii">
     BJU4773
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

